Hanall, Yungjin listed in MSCI index
Published: 2009-05-18 06:58:00
Updated: 2009-05-18 06:58:00
Hanall Pharm and Yungjin Pharm have recently been included in the list of Morgan Stanley Capital International (MSCI) South Korea Index to gauge shares valued $100 million, according to an analyst of Daewoo Securities.
He said that such new listing will give them the potential to attract more ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
